Effects of Combined Sevoflurane and Nitrous Oxide Inhalation - 14

This study has been completed.

First Received on September 20, 1999. Last Updated on October 5, 2011 History of Changes

Sponsor:	University of Chicago
Collaborator:	National Institute on Drug Abuse (NIDA)
Information provided by:	University of Chicago
ClinicalTrials.gov Identifier:	NCT00000262

Purpose

The purpose of this study is to determine the effects of combined sevoflurane and nitrous oxide inhalation on mood, psychomotor performance, and the pain response in humans.

Condition	Intervention	Phase
Opioid-Related Disorders Substance-Related Disorders	Drug: Nitrous oxide	Phase II

Study Type:	Interventional
Study Design:	Primary Purpose: Treatment
Official Title:	Effects of Combined Sevoflurane and Nitrous Oxide Inhalation

Resource links provided by NLM:

MedlinePlus related topics: Drug Abuse

Drug Information available for: Sevoflurane Nitrous oxide

U.S. FDA Resources

Further study details as provided by University of Chicago:

Primary Outcome Measures:

Pain intensity, pain bothersomeness
Mood
Psychomotor performance

Estimated Enrollment:	0
Study Start Date:	November 1996

Eligibility

Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Please contact site for information.

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00000262

Locations

United States, Illinois
University of Chicago, Anesthesia & Critical Care
Chicago, Illinois, United States, 60637

Sponsors and Collaborators

University of Chicago

National Institute on Drug Abuse (NIDA)

Investigators

Principal Investigator:

James Zacny, Ph.D.

University of Chicago

More Information

No publications provided

ClinicalTrials.gov Identifier:	NCT00000262 History of Changes
Other Study ID Numbers:	NIDA-08391-14, R01DA008391, R01-08391-14
Study First Received:	September 20, 1999
Last Updated:	October 5, 2011
Health Authority:	United States: Federal Government

Additional relevant MeSH terms:

Respiratory Aspiration
Opioid-Related Disorders
Substance-Related Disorders
Respiration Disorders
Respiratory Tract Diseases
Signs and Symptoms, Respiratory
Signs and Symptoms
Mental Disorders
Nitrous Oxide
Sevoflurane
Analgesics, Non-Narcotic
Analgesics

Sensory System Agents
Peripheral Nervous System Agents
Physiological Effects of Drugs
Pharmacologic Actions
Central Nervous System Agents
Therapeutic Uses
Anesthetics, Inhalation
Anesthetics, General
Anesthetics
Central Nervous System Depressants
Platelet Aggregation Inhibitors
Hematologic Agents

ClinicalTrials.gov processed this record on February 09, 2012